Diagnostic method, test kit, drug and therapeutic treatment for

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 75, 435 795, 436508, 436513, C12Q 168, G01N 33564

Patent

active

057006415

ABSTRACT:
Synthesized telomeric sequences bind to and can be used for detecting anti-DNA antibodies in serum. Autoimmune diseases such as Lupus Erythematosus, Rheumatoid Arthritis, and Scleroderma, can be detected by detecting an elevated level of anti-DNA antibodies using telomeric sequences. Test kits for such detection are provided including immobilized telomeric sequences capable of binding anti-DNA antibodies. Pharmaceutical compositions for inhibiting or reducing the activity of anti-DNA antibodies contain an effective amount of telomeric sequences effective in inhibiting the antibodies specific to the patient treated.

REFERENCES:
Herren Wu et al., "Building zinc fingers by selection: Toward a therapeutic application", Proc. Natl. Acad. Sci., vol. 92, Jan. 1995, pp. 344-348, Figure 1.
Gabibov Ag et al., "DNA-hydrolyzing autoantibodies", & Appl Biochem Biotechnol 1994, May-Jun.; 47(2-3): pp. 293-302, discussion 303, National Library of Medicine, file Medline.
S.M. Barbas et al., "Recognition of DNA by Synthetic Antibodies", J. Am. Chem. Soc, vol. 116, 1994: pp. 2161-2162.
Dialog Information Services, Derwent database WPI, Dialog accession No. 009259776, WPI accession No. 387189/47, Toshiba KK: "Method of detecting gene by reacting sample with antibody to single stranded oligo-nucleotide--of given base sequence, then detecting presence of antigen-antibody reaction", & JP, A, 4286957, 921012, 9247 (Basic).
National Library of Medicine, file Medline, NLM accession No. 95058242, Schriever-Schwimmer G. et al.: "Differentiation of micronuclei inmouse bone marrow cells: a comparison between CREST staining and fluorescent in situ hybridization with centromeric and telomeric DNA probes", Mutagenesis 1994, Jul.; vol. 9, pp. 333-340.
National Library of Medicine, file Medline, NLM accession No. 95347387, Herrmann M. et al.: "Preferential recognition of specific DNA motifs by anti-double-stranded DNA autoantibodies", & Eur. J. Immunol. 1995, Jul. vol. 25(7): pp. 1897-1904.
E.H. Blackburn, "The Molecular Structure of Centromeres and Telomeres", Ann.Rev Biochem. (1984) 53:163-94.
Virginia A. Zakian, "Structure and Function of Telomeres", Annu.Rev. Genet (1989) 23:579-604.
Elizabeth H. Blackburn, "Structure and Function of Telomeres", Nature.vol. 350. 18 Apr. 1991.
Robert K. Moyzis et al. "A Highly Conserved Repetitive DNA Sequence, (TTAGGG)n, Present at the Telomeres of Human Chromosomes", Proc.Natl.Acad.Sci.USA, vol.85, pp. 6622-6626, Sep. 1988.
Julianne Meyne et al. "Conservation of the Human Telomeres Sequence (TTAGGG)n, Among Vertebrates", Proc.Natl.Acad.Sci.USA, vol. 86, pp. 7049-7053, Sep. 1989.
Alan M. Weiner, "Eukaryotic Nuclear Telomeres: Molecular Fossils of the RNP World?", Cell, vol.52, 155-157, Jan. 29, 1988.
Guo-Liang Yu et al. "In Vivo Alteration of Telomeres Sequences and Senescence Caused by Mutated Tetrahymena Telomeres RNAs", Nature.vol. 344. Mar. 8, 1990.
Calvin B. Harley et al. "Telomeres Shorten During Ageing of Human Fibroblasts", Nature.vol. 345. 31 May 1990.
Shana M. Barbas et al. "Human Autoantibody Recognition of DNA".
John A. Mills, M.D., "Systemic Lupus Erythematosus", vol. 330 No.26, pp. 1871-1879.
Dennis M. Klinman."Polyclonal B Cell Activation in Lupus-Prone Mice Precedes and Predicts the Development of Autoimmune Disease", The Journal of Clinical Investigation, Inc. vol. 86, Oct. 1990, pp.1249-1254.
Dennis M. Klinman et al. "Development of the Autoimmune B Cell Repertorie in MRL-lpr/lpr Mice", The Journal of Immunology vol. 144 pp.506-511, No. 2, Jan. 15, 1990.
Salvador P. Casals et al. "Significance of Antibody to DNA in Systemic Lupus Erythematosus", Arthritis and Rheumatism, vol. 7, No.4 (Aug.), 1964 pp.379-390.
Marc C. Hochberg MD, MPH*, "Systemic Lupus Erthematosus", Rheumatic Disease Clinics of North American--vol. 16, No. 3, Aug. 1990, pp.617-639.
Chandra Mohan et al. "Nucleosome: A Major Immunogen for Pathogenic Autoantibody-Inducing T Cells of Lupus", J. Exp. Med., vol. 177 pp.1367-1381, May 1993.
Eng. M. Tan, "Antinuclear Antibodies:Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology", Advances in Immunology, vol. 44, pp.93-151.
Ajgswaak et al. "Predictive value of Complement Profiles and Anti-dsDNA in Systemic Lupus Erythematosus", Annuals of the Rheumatic Diseases, 1986: 45, 359-366.
E.J. Ter Borg, "Measurement of Increases in Anti-Double-Stranded DNA Antibody Levels as a Predictor of Disease Exacerbation in Systemic Lupus Erythematosus", Arthritis and Rheumatism, vol. 33, No. 5, May 1990 pp. 634-643.
Moshe Pistiner et al. "Lupus Erythematosus in the 1980s: A Survey of 570 Patents", Seminars in Arthritis and Rheumatism, vol. 21, No. 1 Aug. 1991: pp.55-64.
Ellen M. Ginzler, MD, MPH,* et al. "Outcome and Prognosis in Systemic Lupus Erythematosus", Rheumatic Disease Clinic of North American--vol. 14, No. 1, Apr. 1988 pp. 67-78.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostic method, test kit, drug and therapeutic treatment for does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic method, test kit, drug and therapeutic treatment for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method, test kit, drug and therapeutic treatment for will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1801723

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.